A randomized controlled trial comparing a digitally delivered gut-directed hypnotherapy (GDH) program (Nerva) to an active control found that GDH significantly improved IBS symptoms and quality of life. Among 240 participants, 81% of those using the GDH program experienced a ≥50-point decrease in IBS symptom severity compared to 63% in the control group (P = 0.002). GDH also led to a greater reduction in pain (71% vs. 35%, P < 0.001) and quality-of-life improvements (P < 0.001). These findings support digital GDH as an effective and accessible alternative to in-person behavioral interventions for IBS management.
Trending
- Who Adopts AI First: Endoscopists or Humanoid Robots?
- Quest Diagnostics to offer liver cancer blood test (Becker’s GI & Endoscopy)
- Greater Scope: Doctors Get Inside Look at Gut Health With AI-Powered Endoscopy (NVIDIA)
- State of AI in Medicine (Doximity)
- Abbott Acquisition Of Exact Sciences Refocuses Growth On Cancer Diagnostics (Simply Wall Street)
- Will the ‘gestalt’ matter less in GI surgery? (Becker’s GI & Endoscopy)
- Advancing Multidisciplinary Strategies for Obesity Care (AJMC)
- 5 studies scaring gastroenterologists (Becker’s ASC Review)
